type-2

Documents about type-2

• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes#6883OpenAlex
• Social Network Interventions for Improving Dietary Adherence Among Adults With Type 2 Diabetes: A Systematic Review.#9248NCBI PubMed Central
• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial#18541ClinicalTrials.gov
• Scaling Law for Couette-Poiseuille Type Turbulent Flow and Study on 1/2 Power Law and Core Regions#22493J-STAGE (Japan)
• Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes Risk#121248ClinicalTrials.gov
• Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM#121279ClinicalTrials.gov
• The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)#123410ClinicalTrials.gov
• Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age-Associated Gut-Brain Axis Profiles.#125280NCBI PubMed Central
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Diabetes Mellitus#126046ClinicalTrials.gov
• Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes#126058ClinicalTrials.gov
• Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM#136227ClinicalTrials.gov
• Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes#143774ClinicalTrials.gov
• Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors#143791ClinicalTrials.gov
• The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women#148631ClinicalTrials.gov
• Functional genomics reveals mediators of beta cell survival in ER stress and type 2 diabetes risk#148844bioRxiv / medRxiv
• Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance#152578ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV) Food Insecurities#152613ClinicalTrials.gov
• Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance#154823ClinicalTrials.gov
• A Specialized Diet for the Unique Metabolic Characteristics of Peripubertal African American Girls#154832ClinicalTrials.gov
• Investigation for Health Efficacy of Infrared-C Radiation on Diabetes Patients in Senior's Activity Center#154833ClinicalTrials.gov
• The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation#154866ClinicalTrials.gov
• Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy#154887ClinicalTrials.gov
• Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls#158122ClinicalTrials.gov
• Personalized Medicine Interventions for Glycemic Control in Adults With Type 2 Diabetes: A Systematic Review.#170761NCBI PubMed Central
• Corneal and Tear Film Changes in Chinese Patients With Type 2 Diabetes#172484ClinicalTrials.gov
• GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial#172513ClinicalTrials.gov
• Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients#175090ClinicalTrials.gov
• Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control#180293ClinicalTrials.gov
• Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin#180315ClinicalTrials.gov
• Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes#181672ClinicalTrials.gov
• Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness#184761ClinicalTrials.gov
• A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus#162443ClinicalTrials.gov
• Treatment preference for once-weekly versus once-daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials#5184Europe PMC
• A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)#67823ClinicalTrials.gov
• A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor#67840ClinicalTrials.gov
• Global and societal implications of the diabetes epidemic#6239OpenAlex
• Family influences on type 2 diabetes self-management: Perspectives of African American adults with food insecurity.#9414NCBI PubMed Central
• Patients' Perspectives on Telemedicine for Type 2 Diabetes in Primary Care: Systematic Review and Thematic Synthesis.#9633PubMed
• An Analytical Study on the Prevalence of Type-2 Diabetes among American Adults#11953DataCite
• An Analytical Study on the Prevalence of Type-2 Diabetes among American Adults#11954DataCite
• Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease#28470ClinicalTrials.gov
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes#28550ClinicalTrials.gov
• Associations of Combined Genetic and Lifestyle Risks With Incident Type 2 Diabetes in the UK Biobank.#122778NCBI PubMed Central
• Glycemic Targets for Pregnant Women With GDM and T2DM#123411ClinicalTrials.gov
• Diabetes Effects on Long-Term Implant Survival and Success#126006ClinicalTrials.gov
• To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.#127761ClinicalTrials.gov
• Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions#136185ClinicalTrials.gov
• Comparing the Effect of Structured Care Versus Usual Care in Type 2 Diabetes Patients Across the Asia Pacific Region#141200ClinicalTrials.gov
• AIM4 Next Step: Comparing ICS dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation#142674HAL (France)
• Prevention of Coronary Heart Disease in Morbidly Obese Patients#146333ClinicalTrials.gov